• David Becker

    The market selloff over the past couple of trading session has been sharp, with the Nasdaq losing 4% and the broader S&P 500 index declining 2.5%. Momentum stocks have faced an even bigger challenge as the IBB bio-tech ETF ((NASDAQ:IBB) lost nearly 19% since reaching its high in late February. With all the selling, it’s

  • The bio-tech stocks cannot hold a bid, and despite Friday’s stronger than expected payroll data, prices turned lower within the first 10-minutes of trading. The declines in the bio-tech sector continue to weigh on the Nasdaq, along with other momentum stocks. The IBB (Bio-tech iShares ETF) is under pressure on Friday and is poised to